UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

UiPath announced it is expanding its alliance with Deloitte through the launch of Deloitte’s Agentic ERP offering.

"We're also providing a scalable blueprint to expand agentic automation across the enterprise, transforming how business users engage with ERP through seamless collaboration betwe ...

PATH pushes a unified automation platform as enterprises consolidate tools, supporting ARR growth, stronger pilots and ...

UiPath develops enterprise automation technology platforms; Robotic process automation enables digital workflow transformation; UiPath software integrates artificial i ...

Enterprises across the Middle East and beyond are accelerating investments in automation and artificial intelligence, yet many continue to struggle with a familiar challenge: converting promising ...

NEW YORK & BOCA RATON, Fla.--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that it is transforming operations for Omega Healthcare, a ...

UiPath works with a technology known as agentic automation, which is the process of using artificial intelligence to carry out multi-step tasks quickly with limited human input. U ...

On March 12, 2026, investors weighed UiPath’s first full-year profit against slowing growth and divided Wall Street views.

MINNEAPOLIS--(BUSINESS WIRE)--Deluxe, a trusted Payments and Data company, today announced it has been named an UiPath AI25 Award Winner. The annual award program identifies the 25 most innovative ...

UiPath Inc (NYSE: PATH) opened in the red this morning after the firm’s muted full-year outlook tempered its Q4 beat and announcement of a new $500 million share repurchase programme. To some, the ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.